| Title |
Author(s) |
Journal |
Issue Date |
Type |
|
The making of HIV epidemics: what are the driving forces?
|
Caraël, M.; Buvé, A.; Awusabo-Asare, K.
|
AIDS |
1997
|
Article
|
|
HIV/AIDS in Africa: the second decade and beyond
|
Laga, M.; De Cock, K. M.; Kaleeba, N.; Mboup, S.; Tarantola, D.
|
AIDS |
1997
|
Article
|
|
Higher prevalence of parvovirus B19 in Belgian as compared to Tunisian blood donors: differential implications for prevention of transfusional transmission
|
Letaïef, M.; Vanham, G.; Boukef, K.; Yacoub, S.; Muylle, L.; Mertens, G.
|
Transfusion Science |
1997
|
Article
|
|
Sexually transmitted diseases: treating the whole syndrome
|
Laga, M.; Dallabetta, G.
|
Lancet |
1997
|
Article
|
|
Evaluation of the INNO-LiPA Rif. TB assay, a reverse hybridization assay for the simultaneous detection of Mycobacterium tuberculosis complex and its resistance to rifampin
|
Rossau, R.; Traoré, H.; De Beenhouwer, H.; Mijs, W.; Jannes, G.; de Rijk, P.; Portaels, F.
|
Antimicrobial Agents and Chemotherapy |
1997
|
Article
|
|
Inhibitory effects of polyoxyethylene stearate, PANTA, and neutral pH on growth of Mycobacterium genavense in BACTEC primary cultures
|
Realini, L.; Van der Stuyft, P.; De Ridder, K.; Hirschel, B.; Portaels, F.
|
Journal of Clinical Microbiology |
1997
|
Article
|
|
A recombinant prime, peptide boost vaccination strategy can focus the immune response on to more than one epitope even though these may not be immunodominant in the complex immunogen
|
Davis, D.; Morein, B.; Akerblom, L.; Lövgren-Bengtsson, K.; van Gils, M. E.; Bogers, W. M. J. M.; Teeuwsen, V. J. P.; Heeney, J. L.
|
Vaccine |
1997
|
Article
|
|
Reactivity and amplification efficiency of the NASBA HIV-1 RNA amplification system with regard to different HIV-1 subtypes
|
Gobbers, E.; Fransen, K.; Oosterlaken, T.; Janssens, W.; Heyndrickx, L.; Ivens, T.; Vereecken, K.; Schoones, R.; van de Wiel, P.; van der Groen, G.
|
Journal of Virological Methods |
1997
|
Article
|
|
HIV-1 subtypes: implications for epidemiology, pathogenicity, vaccines and diagnostics; workshop report
|
Unknown author |
AIDS |
1997
|
Article
|
|
CD8+ cells and not CD4+ T cells are hyporesponsive to CD28- and CD40L-mediated activation in HIV-infected subjects
|
Vingerhoets, J.; Kestens, L.; Penne, G.; De Vuyst, H.; Vandenbruaene, M.; Pelgrom, Y.; Bosmans, E.; de Boer, M.
|
Clinical and Experimental Immunology |
1997
|
Article
|